Medical Developments International Limited (ASX:MVP)
Australia · Delayed Price · Currency is AUD 0.4750
0.00 (0.00%)
Aug 21, 2026, 4:10 PM AEST
ASX:MVP Market Cap
ASX:MVP has a market cap or net worth of 53.51 million as of August 21, 2026. Its market cap has decreased by -25.20% in one year.
Market Cap
53.51M
Enterprise Value
40.81M
Revenue
42.57M
Ranking
n/a
PE Ratio
89.62
Stock Price
0.48
ChartMarket Cap Chart
Since December 19, 2003, ASX:MVP's market cap has increased from 29.06M to 53.51M, an increase of 84.15%. That is a compound annual growth rate of 2.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 53.51M | -14.41% |
| Dec 31, 2025 | 62.53M | 37.04% |
| Dec 31, 2024 | 45.63M | -30.44% |
| Dec 29, 2023 | 65.59M | -48.65% |
| Dec 30, 2022 | 127.73M | -64.16% |
| Dec 31, 2021 | 356.40M | -23.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vita Life Sciences | 155.05M |
| Little Green Pharma | 60.44M |
| Syntara | 52.97M |
| Peak Processing | 20.60M |
| IDT Australia | 17.52M |
| Vitura Health | 16.57M |
| Epsilon Healthcare | 10.12M |
| Percheron Therapeutics | 8.37M |